tufts csdd's 2019 postgraduate course
Tufts CSDD's 46th Annual Postgraduate Course in Clinical Pharmacology, Drug Development and Regulation
Ritz-Carlton Hotel, Boston, MA | February 4-8, 2019
Tufts CSDD’s highly acclaimed, CME accredited, five-day Postgraduate Course in Clinical Pharmacology, Drug Development and Regulation provides advanced instruction in practical and technical problem-solving in the areas of clinical pharmacology, drug development & clinical trial strategies, biopharmaceutical development, drug safety, and new drug regulation. During an exclusive Q&A session with a senior FDA official, participants will receive first-hand insights into FDA priorities and operations, and will emerge with a better understanding of the regulatory process.
WHO SHOULD ATTEND
Physicians, pharmacists, marketing executives, clinical researchers, nurses, analysts, investors and any professional working with or in the research-based drug industry
Professionals looking to begin work in the pharma or biotech sectors, and are seeking comprehensive and foundational industry knowledge and training
Individuals employed by regulatory agencies, academic institutions, outsourcing providers, consultancy firms, niche service providers, and other organizations involved in the research, development, and regulation of pharmaceutical products
NOTE: Please see the course brochure for CME accreditation information.
The CSDD Postgraduate Course is designed to provide students with a broad and comprehensive understanding of issues related to the development and regulation of drugs, biologics, vaccines, devices, and in vitro diagnostics. Lectures focus on basic drug development topics - such as translational medicine, clinical pharmacology, epidemiology, drug regulation, and adverse drug event reporting - as well as broader topics - such as pharmacoeconomics, drug-device combinations, biosimilars, working with investigative sites, and drug marketing.
Educational Objectives for CME
Clinical Pharmacology: Integrate the relevant pharmacology, pharmacokinetics, and statistics related to drug development and the nature of evidence required for proof of efficacy and safety.
Drug Development and Clinical Trials: Using a case-study approach, identify and solve practical, theoretical, and technical problems in human drug studies, and analyze an experimental design for a new drug candidate.
Regulation: Evaluate the science, laws, and regulations pertaining to the development and review of new drug products in the USA, Europe, Japan and other pharmaceutical markets.
Early Bird Sponsor Rate: $4,595 (before September 1, 2018)
Advance Registration: $4,795 (September 2, 2018 - December 1, 2018)
Regular Rate: $4,995 (December 2, 2018 - February 4, 2019)
Academic/Government/Non-profit Rate: $2,995
Discounted rate for groups of 3 or more, e-mail firstname.lastname@example.org or call us at 617-636-2170 for more information.
The 46th Annual Tufts CSDD Postgraduate Course will be taking place at the Ritz-Carlton Boston hotel.
FEEDBACK FROM PAST PARTICIPANTS
"Taking the Tufts course was a tremendously beneficial experience for me. I'm so grateful to have learned so much and met such wonderful colleagues. You created a fantastic roster of speakers and presentations."
“Being new to the industry I appreciated that all the presentations provided excellent background information before examining each topic in more depth.”
“The Regulation overview for US, EU, Japan, and China were extremely useful. The presentation captured essential knowledge for those areas.”
“The mock drug groups activity was very helpful because it brought together a handful of people from different backgrounds and professions. It encouraged team-building and communication - two things that are very much needed in the work field.”